FDA says Wegovy and Ozempic shortage resolved; Hims & Hers stock falls

Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie Adams | Reuters The long-running U.S. shortage of Novo Nordisk‘s blockbuster weight loss injection Wegovy and diabetes treatment Ozempic is resolved after more than two years, the U.S. Food and Drug Administration said Friday.  The FDA’s decision will threaten the … Read more

UnitedHealth faces DOJ investigation, buyouts, stock price drop

FILE PHOTO: The logo of Down Jones Industrial Average stock market index listed company UnitedHealthcare is shown in Cypress, California April 13, 2016.  Mike Blake | Reuters UnitedHealthcare is in hot water again as the insurance giant grapples with a reported government investigation of its Medicare billing practices, pursues employee buyouts and potential layoffs, and … Read more

Bluebird Bio gene therapy sells itself to Carlyle and SK Capital

Sopa Images | Lightrocket | Getty Images Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday, marking the end of the Bluebird’s fall from the one of the buzziest biotech firms to one that was on the cusp of running out of money. … Read more

Hims & Hers to offer at-home blood draws, lean into peptides

The New York Stock Exchange with a Hims & Hers Health banner is pictured in the Manhattan borough of New York City. Carlo Allegri | Reuters Hims & Hers Health announced Wednesday it has acquired New Jersey-based at-home lab testing facility Trybe Labs. The deal will allow the telehealth company to offer at-home blood draws … Read more

Eli Lilly Dan Skovronsky discusses weight loss drugs

Dan Skovronsky knows what makes a good obesity drug. As chief scientific officer at Eli Lilly, he’s already done it once with the company’s weekly shot, Zepbound. He’s trying to do it again with a more convenient daily pill, then repeat the feat with a shot that could be even more powerful than Zepbound. And … Read more

Eli Lilly to take big swings in Alzheimer’s, ALS and gene therapy

Heart disease. Hearing loss. Addiction. Chronic pain. Alzheimer’s. ALS. These are some of the areas where Eli Lilly, flush with cash from its GLP-1 drugs, wants to make big bets.  These are the ideas that are “hiding in plain sight,” said Lilly Chief Scientific Officer Dan Skovronsky. They’re places where other pharmaceutical companies might not … Read more

UnitedHealthcare offers buyouts, could pursue layoffs

A general view outside the United Healthcare corporate headquarters on December 4, 2024 in Minnetonka, Minnesota.  Stephen Maturen | Getty Images UnitedHealthcare is offering certain employees in its benefits operations unit the option to accept buyouts if they quit by March 3, following a tumultuous year for the insurance giant, CNBC has learned. Those who … Read more

Ozempic helps curb alcohol use in new study

Steve Christo | Corbis News | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Novo Nordisk‘s blockbuster diabetes drug Ozempic may also help people drink less alcohol.  That’s according to new government-funded research … Read more

AI startup OpenEvidence secures Sequoia funding, $1 billion valuation

Medical technology, AI technology is utilized by doctors for diagnosing increasing the accuracy of patient treatments. Medical research and development innovation technology to improve patient health. Pcess609 | Istock | Getty Images AI startup OpenEvidence is raising a fresh round of capital from Sequoia to scale its chatbot for doctors.  The new $75 million cash … Read more

Measles outbreak grows bigger in rural Texas, and officials expect more cases

A vial of the measles, mumps, and rubella (MMR) vaccine is pictured at the International Community Health Services clinic in Seattle, Washington. Lindsey Wasson | Reuters At least 58 new cases of measles have been reported across northwest Texas in recent weeks, state health officials said Tuesday, in a “highly contagious” outbreak that might be linked to … Read more